LMP Hits Pause on Somerville Lab Project
A third major Somerville lab development is hitting the brakes amid the growing glut of life science space in the city.
A third major Somerville lab development is hitting the brakes amid the growing glut of life science space in the city.
The first decade of the Boston Seaport District development boom full of low-hanging fruit. Today, Oxford Properties Group and the owners of Pappas Commerce Center have to navigate a trickier path.
2024 promises to be a year of reckoning for many Boston-area commercial property owners as rising vacancies and expiring mortgages threaten their once-lucrative business plans.
Proposed changes to one of the last big development frontiers in Boston’s Seaport District include replacement of warehouses and parking lots with eight new buildings, including 1.3 million square feet for research and development tenants and 205 housing units.
Moderna will open a new 140,000-square-foot biomanufacturing plant next year that’s being developed by Oxford Properties Group on a 24-acre site.
A steakhouse and lounge featuring live music and outdoor dining will make its Boston debut in early 2024 in Back Bay.
Industrial parcels on the far reaches of the Seaport District are due for their first major changes in decades with development plans being drawn up by Oxford Property Group.
A biomanufacturing facility nearing completion in Marlborough was acquired by Oxford Properties for $125 million through a sale-leaseback.
Despite the general softening of the local life science real estate market, a major pension fund has decided to back Somerville’s latest spec lab high-rise.
Despite the general softening of the life science real estate market, a major pension fund has decided to back Somerville’s latest spec lab high-rise.
CRISPR Therapeutics’ new Framingham manufacturing facility was recognized for innovation in a recent awards category by the International Society of Pharmaceutical Engineering.
An office building across from Boston’s South Station will become life science research space after a developer confirmed no high-risk infectious disease research will be conducted.
The record-breaking $825.1 million sale of One Memorial Drive demonstrates the Cambridge tech hub’s continuing appeal to institutional real estate investors.
The departure of anchor tenant WeWork is providing the impetus for the latest proposed office-to-lab conversion in downtown Boston.
A pair of biotech leases totaling 38,000 square feet have brought Oxford Properties Group’s 645 Summer St. property up to 100 percent occupancy.
An office tower proposed for Boston’s Leather District that’s attracted complaints about excessive height next to the Rose Fitzgerald Kennedy Greenway is scaling back its profile – while redesigning larger floor plates for life science labs.
Major life science developer King Street Properties has sold three Framingham properties to the investment arm of a major Canadian pension fund.
Oxford Properties Group hired Elkus Manfredi Architects to update 222 Berkeley St., a 550,000-square-foot Back Bay office building designed by Robert A.M. Stern Architects and completed in 1991.
Oxford Properties Group made a splash in 2014 with its big-ticket arrival in Massachusetts, buying five trophy office buildings in Boston and Cambridge. To spearhead its next effort, Oxford in 2018 hired Mark McGowan as its local head of development.
A Boston-based marketing company has signed on to lease nearly 160,000 square feet at an office tower steps to South Station.